ArticlePharmacoepidemiology and drug safety2024

Post-Marketing Safety of Ustekinumab Based on 14-Year Follow-Up in Danish National Patient Data.

Sejun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.